Global Export of Insulin in Dosage Forms by Country

The global export of insulin in dosage forms presents a diverse landscape of contributors with notable variations. In 2023, France led the market with 7.5661 million kilograms, followed by India at 5.0141 million kilograms and Italy at 2.8898 million kilograms. Among the key exporters, France, India, Italy, Germany, and the United States showed year-on-year variation percentages of 4.01%, 4.11%, 5.89%, 3.06%, and 1.73% respectively, indicating stable market presence. Slovenia and Estonia exhibited significant growth spurts with year-on-year increases of 170.58% and 25.01%, becoming countries to watch. Brazil and Serbia witnessed declining trends, emphasizing regional shifts. Notably, China and Russia demonstrated modest but consistent annual increases, reflecting their growing roles in the market.

Future trends that warrant close attention include:

- The potential impact of emerging markets such as Slovenia and Estonia.

- The influence of regulatory changes and biotechnological advancements in major exporting countries.

- Shifts in demand and supply dynamics due to innovations in biosimilar insulin products.

- The global economic environment, which may affect export capacities and strategic international trade agreements in the insulin market.

Top countries in Export of Insulin in Dosage Forms by Country

# 10 Countries Kilograms Last Year YoY 5-years CAGR
1 1 France 7,566,100 2023 +1.98% +4.01% View data
2 2 India 5,014,100 2023 +1.65% +4.11% View data
3 3 Italy 2,889,800 2023 +4.07% +5.89% View data
4 4 Germany 2,644,900 2023 +2.57% +3.06% View data
5 5 United States 2,306,200 2023 +0.73% +1.73% View data
6 6 China 1,014,000 2023 +5.43% +5.18% View data
7 7 Brazil 702,040 2023 -10.23% -7.39% View data
8 8 Hungary 435,170 2023 +2.09% +1.49% View data
9 9 Belgium 368,510 2023 +4.65% +4.77% View data
10 10 United Kingdom 284,980 2023 +3.19% +3.34% View data

Top Countries about Insulin